Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 61,550 shares at $40.36 ($2.5M) on 2018-06-25, disclosed to the SEC on 2018-06-27.
Open-market sale of $2.5M BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.36 | 18,860 | $761K | 30.5% |
| 2 | $40.36 | 18,860 | $761K | 30.5% |
| 3 | $40.74 | 900 | $37K | 1.5% |
| 4 | $40.78 | 1,000 | $41K | 1.6% |
| 5 | $40.79 | 900 | $37K | 1.5% |
| 6 | $40.86 | 9,790 |
| $400K |
| 16.0% |
| 7 | $40.86 | 9,790 | $400K | 16.0% |
| 8 | $41.27 | 210 | $9K | 0.3% |
| 9 | $41.31 | 1,140 | $47K | 1.9% |
| 10 | $41.46 | 100 | $4K | 0.2% |
| Total | $40.56 avg | 61,550 | $2.5M | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |